Rheumatoid Arthritis Treatment, Product Administration, Training and Patient Assistance/Compassionate Use Program Awareness for the Specialty

Save this PDF as:
 WORD  PNG  TXT  JPG

Size: px
Start display at page:

Download "Rheumatoid Arthritis Treatment, Product Administration, Training and Patient Assistance/Compassionate Use Program Awareness for the Specialty"

Transcription

1 Rheumatoid Arthritis Treatment, Product Administration, Training and Patient Assistance/Compassionate Use Program Awareness for the Specialty Pharmacist and the Collaborative Healthcare Team

2 Disclaimer The information within this CME/CE activity is for continuing education purposes only, and is not intended to substitute for the medical judgment of the healthcare provider. Recommendations for use of any particular therapeutic agents or methods are based upon the best available scientific evidence and clinical guidelines. Reference in this activity to any specific commercial products, process, service, manufacturer, or company does not constitute its endorsement or recommendation. Developer discloses that he is a speaker, consultant, and provides research support for the National Association of Specialty Pharmacy. He does not intend to discuss non-fda approved drugs or investigational use of any product/device.

3 Faculty Biography University of Florida 2008 Pharmacist in Charge Publix Super Markets National Association of Specialty Pharmacy Specialty Pharmacy Clinical Consultant Michael J Crocco, PharmD, RPh, CSP Specialty Pharmacy Clinical Services National Association of Specialty Pharmacy Specialty Pharmacy Education Center Reviewer/author of CE s Specialty Pharmacy Certification Board Subject matter expert in developing Certified Specialty Pharmacy Credential Certified Specialty Pharmacist

4 Objectives Recognize the various inflammatory autoimmune disorders and their distinguishing features. Identify current treatment options for RA and review their appropriate administration Identify the three biggest barriers to adherence & persistence and how Specialty Pharmacists and the collaborative healthcare team can anticipate & overcome those barriers Identify RA patient assistance programs from RA manufacturers and 3 rd parties Describe the specialty pharmacist and the collaborative healthcare team s role in RA condition management resulting in cost-effective care

5 Other Autoimmune Diseases (Brief Overview)

6 Crohn s Disease Inflammatory Bowel Disease Lining of digestive tract (mouth to anus) Signs/Symptoms Abdominal pain Severe diarrhea Blood in stool Ulcers Reduced appetite Weight loss e.svg

7 Ulcerative Colitis Inflammatory bowel disease Lining of large intestine Types of UC: Proctitis Proctosigmoiditis Left-sided Colitis Pancolitis Fulminant Colitis pg

8 Psoriatic Arthritis Enthesitis Characteristic feature Signs/Symptoms Similar to RA, plus.. Swollen fingers and toes Foot pain Lower back pain

9 Juvenile Idiopathic Arthritis Children 6 months 16 years old Types of JIA Pauciarticular Polyarticular Systemic

10 Juvenile Idiopathic Arthritis Symptoms Pain Swelling Stiffness Swollen lymph nodes Rash Fever

11 Ankylosing Spondylitis Spine Vertebrae fuse Signs/Symptoms Lower back pain Hip pain

12 Treatment Options Rheumatoid Arthritis

13 DMARDs Methotrexate (Trexall, Rheumatrex) Leflunomide (Arava) Hydroxychloroquine (Plaquenil) Sulfasalazine (Azulfidine)

14 Methotrexate Dosing Once weekly Oral or injection (IM or SQ) Titrate up as necessary Hydration Monitoring LFT s CBC w/diff Platelets BUN/Cr

15 htm Methotrexate SQ Injection 25 Gauge 1/2-5/8 inch

16 Methotrexate IM Injection 25 Gauge inch htm

17 Leflunomide Dosing Loading dose of 100mg x 3 days 20mg daily thereafter With food Monitoring BP Platelets WBC s Hgb/Hct LFT s

18 Leflunomide Drug elimination procedure Cholestyramine 8g TID x 11 days Plasma levels <0.02mg/dL 2 tests, 14 days apart If no elimination procedure Up to 2 years to reach <0.02mg/dL

19 Hydroxychloroquine Weight based dosing 6.5mg/kg /day Typically mg daily Monitoring Eye exams Yearly Keep away from children Small doses fatal

20 Sulfasalazine Dosing mg Q12H Up to 4000mg daily Monitoring CBC w/diff LFTs BUN/Cr Caution Sulfonamide allergy Salicylate allergy

21 TNFa Inhibitors Humira (Adalimumab) Enbrel (Etanercept) Cimzia (Certolizumab pegol) Simponi (Golimumab) Remicade (Infliximab)

22 Humira Dosing 40mg SQ q2wk 40mg SQ qwk if not on MTX Refrigerate Monitor Hep B antigen PPD s/sx TB and HBV Cost $2400-$2700 (2 pens/syringes)

23 Humira Administering Pen Clear/colorless liquid No particles Front of thighs/lower abdomen Clean area Gently squeeze skin and hold firmly Hold pen at 90 degree angle Push plum colored button until clicks Hold for 10 seconds Yellow Indicator = Completed Do not rub area 2IpGLsVangU/UEktd63ThII/AAAAAAAAAJw/wmt8vVOYiC8/s1600/humira1.jpg

24 Humira Administering Prefilled Syringe Clear/colorless liquid No particles Front of thighs/lower abdomen Clean area Gently squeeze skin and hold firmly Insert at 45 degree angle and let go of skin After injecting, remove at same angle Do not rub area 8QaFwE1vRfE/T819tbn5jQI/AAAAAAAAACk/gAjBd3WTGPo/s1600/humira.jpg

25 Humira Patient Assistance Programs myhumira Humira Protection Plan 24/7 on-call nurse support HUMIRA Injection training kit Sharps container Medication reminders On-the-go kit Abbvie Patient Assistance Foundation

26 Enbrel Dosing 50mg SQ qwk OR 25mg SQ 2x/wk 72-96h apart Storage Refrigerate Room temperature 14 days Monitor Hep B antigen PPD s/sx TB and HBV Dermatologic exam* Cost $2200-$3000

27 Enbrel Administering SureClick AutoInjector Clear/colorless liquid Front of thighs preferred Abdomen/outer are of upper arms Clean area Stretch skin to make it firm and taut Hold pen at 90 degree angle Press pen firmly to unlock safety guard Press and release purple button Hold firmly for 15 seconds Purple Indicator = Completed Do not rub area pg

28 Enbrel Administering Enbrel PFS Clear/colorless liquid Front of thighs/lower abdomen/outer upper arms Clean area Gently squeeze skin and hold firmly Inject at 45 degree angle Do not rub area

29 Enbrel PAP Enbrel Support Card Education Injection training Medication refill reminders Live nurse support ENBREL Starter kit Sharps mail-back program Travel pack

30 Enbrel Support Card If commercial insurance: $0 for 6 months, $10 afterwards If Government insurance: Connect with independent foundations Low-income subsidy assistance If Uninsured: ENcourage Foundation

31 Cimzia Dosing 400mg SQ on week 0, 2, 4, then 200mg SQ q2wk OR 400mg SQ q4wk Refrigerate Monitor Hep B antigen PPD s/sx TB and HBV Dermatologic exam* Cost ~$2500

32 Cimzia Administration Room temperature 30 minutes Clear/colorless liquid Front of thighs/lower abdomen Clean area Gently squeeze skin and hold firmly Inject at 45 degree angle Do not rub area

33 Cimzia PAP Cimplicity Treatment and patient support Home Health Nurse CIMZIA Education Injection training Insurance coverage verification Cimzia Co-pay Savings Card Program Up to 12 months at no cost Additional financial assistance

34 Simponi Dosing 50mg SQ monthly with MTX Refrigerate Monitor Hep B antigen PPD s/sx TB and HBV Dermatologic exam* Cost ~$8300 (5 syringes)

35 Simponi SmartJect Autoinjector Administration Room temperature 30 minutes Clear/slightly yellow Front of thighs/lower abdomen/outer area of upper arms Clean area Inject at 90 degree angle Press firmly against skin to unlock safety sleeve Press button until clicks hold until clicks again Do not rub area Shot.jpg

36 Simponi Prefilled Syringe Administration Room temperature 30 minutes Clear/slightly yellow Front of thighs/lower abdomen/back of upper arms Clean area Gently squeeze skin and hold firmly Inject at 45 degree angle Hold plunger until removed from skin then release Do not rub area PG

37 SimponiOne Support Injection Support Nurse Support MY SIMPONI RN Live Link (on-line discussion) 7 days/wk, 8am-11pm SmartJect Autoinjector Reusable Trainer Included in Welcome Pack Demonstration Videos

38 SimponiOne Support Treatment Support Simponi Welcome Pack SimponiOne Safe Returns Once a year return service Holds 12 SmartJect autoinjectors Holds more syringes Travel Pack Travel Advisory Card

39 SimponiOne Support Medication Cost Support Commercial/Private Insurance $5/month up to $8000 benefit/yr Government Insurance independent foundation No insurance Johnson & Johnson Patient Assistance Foundation Other

40 Remicade Dosing 3mg/kg IV on wk 0, 2, 6 THEN 3mg/kg IV q8wk Use with MTX Max dose 10mg/kg OR 3mg/kg q4wk Refrigerate Monitor Hep B antigen PPD s/sx TB and HBV Dermatologic exam* Cost $ for one vial (100mg)

41 Remicade Administration Colorless/light yellow By medical professional Infusion Center At least 2 hours

42 Remicade PAP AccessOne Care Coordinator Access-1 M-F, 8am-8pm EST Infusion site locations Newsletters Education materials Appointment reminders Emergency outreach services

43 Remicade PAP RemiStart Patient Rebate Program Co-pay assistance Up to 12 months, 8 infusions, or $8000 RemiStart Extended Access Program Must meet eligibility requirements

44 Other Biologics Kineret (Anakinra) Orencia (Abatacept) Rituxan (Rituximab) Actemra (Tocilizumab)

45 Kineret Dosing 100mg SQ q24h Refrigerate Monitor Cr ANC Pregnancy Category B Cost ~$3000/28 syringes

46 Kineret Prefilled Syringe Administration Sit at room temperature minutes Clear/colorless Sites Outer area of upper arms Upper outer areas of buttocks Abdomen Front of the middle thighs Gently pinch fold of skin Inject at 45 or 90 degree angle gif

47 Kineret PAP KineretKare Program Copay assistance Up to $300/month OR $3600/year Delivery of medication Access to KineretKare specialist M-F, 8am-6pm EST

48 Orencia Weight based dosing <60kg 500mg IV on wk 0, 2, 4, then q4wk OR 500mg IV x1, then 125mg SQ w/in 24hr, then 125mg SQ qwk kg same as above but 750mg IV doses >100kg same as above but 1000mg IV doses Refrigerate Monitor Cost Hepatitis panel PPD at baseline $2100/vial (250mg) $2500/4 syringes (125mg)

49 Orencia Administration IV Medical professional Reconstitute with 10ml sterile water for injection Must use silicone free syringe provided 30 minute infusion

50 Orencia Administration SQ Clear/colorless/pale yellow Room temperature minutes Sites Front of thigh Upper outer arms Abdomen Gently pinch skin and hold firmly Inject at 45 degree angle Ulnq7gEQ1NM/UqNeD7LnvSI/AAAAAAAATEo/vQpbAc01osY/s1600/orencia.jpg

51 Orencia PAP Orencia On Call Personal care counselor Available 24/ ORENCIA Copay assistance Welcome pack Sharps Disposal Service Drug Replacement If damaged Insurance questions

52 Orencia PAP Orencia Copay Assistance Program Covers cost of drug only Infusion patients $5 out of pocket per infusion $8000/year max benefit NOTE: state or federally funded insurance excluded

53 Rituxan Dosing 1000mg IV on days 1 and 15 THEN 1000mg IV q24 weeks Q16 weeks In combination with MTX Refrigerate Cost ~$15,600 (one 10ml vial = 10mg/ml)

54 Rituxan Monitoring HBsAg Anti-HBc at baseline CBC Platelets ECG s/sx of hepatitis or HBV reactivation

55 Rituxan Administration IV infusion Medical professional Pre-medicate APAP and antihistamine Methylprednisolone 100mg IV (RA patients only)

56 Rituxan Infusion Rates Initial Infusion = 50mg/hr Increase at 50mg/hr increments q30 minutes Max 400mg/hr Subsequent infusions = 100mg/hr Increase at 100mg/hr at 30 minute intervals Max 400mg/hr

57 Rituxan PAP Join Rituxan and You Genentech Rheumatology Access Solutions Genentech Access to Care Foundation Genentech Rheumatology Co-pay Card Program $10,000 over 12 months $5 per co-pay May reuse if still eligible after 12 months

58 Actemra IV Dosing 4mg/kg IV over 1 hour q4wks May increase to 8mg/kg IV q4wks Do not exceed 800mg per infusion SQ Dosing 162mg SQ qwk If pt <100kg, start at 162mg SQ q2wks Refrigerate Cost $340 (4ml vial) $850 (10ml vial) $1725 (20ml vial)

59 Actemra Monitoring PPD at baseline s/x of TB CBC w/differential (ANC s) Platelets LFT s Lipid profile

60 Actemra Administration IV Infusion Clear/colorless/pale yellow Medical professional Room temperature Infuse over 60 minutes Use separate IV line pg

61 Actemra Administration SQ Room temperature 30 minutes Sites Front of thigh Outer area of upper arm Abdomen Gently pinch skin Inject at 45 or 90 degree angle Release pinched skin and inject

62 Actemra PAP Actemra Access Sampling Program SQ patients ACT Fast Program 6 months free Support for Medicare Part D patients Refer to LIS Program Genentech Access to Care Foundation Extension

63 Actemra Access Actemra and You Symptom Tracker Calendar Doctor Discussion Guide Nurse Help Line ACTEMRA 6am-12am EST SC Injection tools Travel Pack Sharps Container Injection Reminder Service Treatment Tracker

64 Actemra Access Genentech Rheumatology Co-pay Card Program $10,000 per 12 months $5 co-pay Genentech Rheumatology Access Solutions

65 JAK inhibitor Xeljanz (Tofacitinib)

66 Xeljanz Dosing 5mg PO BID With or w/o food Room temperature Monitoring CBC w/diff Lipid panel LFT s Cost ~$2,000 (60 tablets)

67 XelSource Private Insurance Free Trial Offer Personal Support M-F, 8am-8pm EST Xeljanz Copay Savings Card $0 copay $8,000 benefit per calendar year Uninsured XelSource Patient Assistance Program

68 Xeljanz Government Insurance Personal Support Financial Assistance State Pharmaceutical Companies Low-income subsidies Charitable foundations Hardship support Xeljanz + You Welcome Kit Refill reminders Tips, Tools, and Resources

69 Other Patient Assistance Programs NeedyMeds Diplomat s Co-pay Assistance Navigator HealthWell Foundation Patient Access Network Foundation Bristol-Myers Squibb Patient Assistance Foundation Orencia Pfizer Pfriends Xeljanz

70 Other Patient Assistance Programs Partnership for Prescription Assistance Humira MedLink Prescription Assistance Enbrel Janssen Prescription Assistance Simponi, Remicade Johnson & Johnson Prescription Assistance Foundation Remicade

71 Barriers to Adherence Cost Direct Indirect Administration Complicated/intimidating Transportation/Time Infusions Side effects Cancer Infertility Pain

72 Overcoming Barriers Treatment management Counsel/Educate Side effects Self injections Insurance No more pre-existing condition Use assistance programs Home health nurse Specialty Pharmacist

73 Conclusion Multiple treatment options Biologics are expensive All have assistance programs Make patients aware Need to educate/counsel all patients

74 References Mayoclinic. Crohn s Disease. Accessed on November 19, Crohn s and Colitis Foundation of America. What is Crohn s Disease? Accessed on November 19, Mayoclinic. Ulcerative Colitis. Accessed on November 19, Crohn s and Colitis Foundation of America. What is Ulcerative Colitis. Accessed on November 19, American College of Rheumatology. Psoriatic Arthritis. Psoriatic_Arthritis/. Accessed on November 21, Mayoclinic. Psoriatic Arthritis. Accessed on November 21, 2013.

75 References Mayoclinic. Juvenile Rheumatoid Arthritis. Accessed on November 21, National Institute of Arthritis and Musculoskeletal and Skin Diseases. What is Juvenile Arthritis? Accessed on November 21, WebMD. Understanding Juvenile Rheumatoid Arthritis. Accessed on November 21, Mayoclinic. Ankylosing Spondylitis. Accessed on November 22, American College of Rheumatology. Methotrexate. xate_(rheumatrex,_trexall)/. Accessed on November 22, 2013.

76 References Brooks PJ, Spruill WJ, Parish RC, Birchmore DA. Pharmacokinetics of methotrexate administered by intramuscular and subcutaneous injections in patients with rheumatoid arthritis. Department of Pharmacy Practice, University of Georgia College of Pharmacy, Athens. Arthritis Rheum Jan;33(1):91-4. Mayoclinic. Leflunomide. Accessed on November 24, Sanofi-Aventis. Arava Package Insert. Accessed on November 24, Mayoclinic. Hydroxychloroquine. Accessed on December 5, Mayoclinic. Sulfasalazine. Accessed on December 5, 2013.

77 References Patient Assistance Programs. Accessed January 20, 2014 February 27, Humira Product Information and Patient Assistance Programs. Accessed on January 15, Enbrel Product Information and Patient Assistance Programs. Accessed on January 15, Cimzia Product Information and Patient Assistance Programs. Accessed on January 16, Simponi Product Information and Patient Assistance Programs. Accessed on January 16, Remicade Product Information and Patient Assistance Programs. Accessed on January 18, Kineret Product Information and Patient Assistance Programs. Accessed on January 24, 2014.

78 References Orencia Product Information and Patient Assistance Programs. Accessed on January 31, Rituxan Product Information and Patient Assistance Programs. Accessed on February 10, Actemra Product Information and Patient Assistance Programs. Accessed on February 12, Xeljanz Product Information and Patient Assistance Programs. Accessed on February 15, Micromedex Healthcare Series [Internet database]. Greenwood Village, Colo: Thomson Healthcare. Updated periodically. Epocrates Epocrates Mobile Application. Retrieved from

79 Q & A

80 This program has been brought to you by The National Association of Specialty Pharmacy and its education provider The Specialty Pharma Education Center. Claim Credit Instructions: Visit & type session code: (session codes are also located in your program guide on the activity sheet page) *All users must complete the pre AND post test to receive statement of credit. Credit must be claimed within 30 days of this program.

(continued) MEDICATION GUIDE Rx Only KEVZARA (KEV-za-ra) (sarilumab) injection, for subcutaneous use

(continued) MEDICATION GUIDE Rx Only KEVZARA (KEV-za-ra) (sarilumab) injection, for subcutaneous use MEDICATION GUIDE KEVZARA (KEV-za-ra) (sarilumab) injection, for subcutaneous use Rx Only What is the most important information I should know about KEVZARA? KEVZARA can cause serious side effects including:

More information

INSTRUCTIONS FOR USE ORENCIA (oh-ren-see-ah) (abatacept) Prefilled Syringe with BD UltraSafe Passive Needle Guard

INSTRUCTIONS FOR USE ORENCIA (oh-ren-see-ah) (abatacept) Prefilled Syringe with BD UltraSafe Passive Needle Guard INSTRUCTIONS FOR USE ORENCIA (oh-ren-see-ah) (abatacept) Prefilled Syringe with BD UltraSafe Passive Needle Guard ORENCIA Prefilled Syringe with BD UltraSafe Passive TM Needle Guard (abatacept) Injection

More information

First Name. Specialty: Fax. First Name DOB: Duration:

First Name. Specialty: Fax. First Name DOB: Duration: Prescriber Information Last ame: First ame DEA/PI: Specialty: Phone - - Fax - - Member Information Last ame: First ame Member ID umber DOB: - - Medication Information: Drug ame and Strength: Diagnosis:

More information

MEDICATION GUIDE HUMIRA

MEDICATION GUIDE HUMIRA MEDICATION GUIDE HUMIRA (Hu-MARE-ah) (adalimumab) injection Read the Medication Guide that comes with HUMIRA before you start taking it and each time you get a refill. There may be new information. This

More information

ADALIMUMAB Generic Brand HICL GCN Exception/Other ADALIMUMAB HUMIRA GUIDELINES FOR USE INITIAL CRITERIA (NOTE: FOR RENEWAL CRITERIA SEE BELOW)

ADALIMUMAB Generic Brand HICL GCN Exception/Other ADALIMUMAB HUMIRA GUIDELINES FOR USE INITIAL CRITERIA (NOTE: FOR RENEWAL CRITERIA SEE BELOW) Generic Brand HICL GCN Exception/Other ADALIMUMAB HUMIRA 24800 GUIDELINES FOR USE INITIAL CRITERIA (NOTE: FOR RENEWAL CRITERIA SEE BELOW) 1. Does the patient have a diagnosis of moderate to severe rheumatoid

More information

For Rheumatoid Arthritis

For Rheumatoid Arthritis For Rheumatoid Arthritis APRIL 2017 NOTICE: On April 14, 2017 the FDA issued a complete response letter for baricitinib indicating that the FDA is unable to approve the application in its current form

More information

MEDICATION GUIDE. (tocilizumab)

MEDICATION GUIDE. (tocilizumab) MEDICATION GUIDE ACTEMRA (AC-TEM-RA) (tocilizumab) Read this Medication Guide before you start ACTEMRA and before each infusion. There may be new information. This Medication Guide does not take the place

More information

Steps TO HELP YOU TALK WITH YOUR DOCTOR ABOUT YOUR TREATMENT OPTIONS

Steps TO HELP YOU TALK WITH YOUR DOCTOR ABOUT YOUR TREATMENT OPTIONS Moderate to Severe Rheumatoid Arthritis (RA) 3 Steps TO HELP YOU TALK WITH YOUR DOCTOR ABOUT YOUR TREATMENT OPTIONS INDICATION/USAGE Adult Rheumatoid Arthritis (RA): ORENCIA (abatacept) is a prescription

More information

Immune Modulating Drugs Prior Authorization Request Form

Immune Modulating Drugs Prior Authorization Request Form Patient: HPHC member ID #: Requesting provider: Phone: Servicing provider: Diagnosis: Contact for questions (name and phone #): Projected start and end date for requested Requesting provider NPI: Fax:

More information

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Medical Policy An independent licensee of the Blue Cross Blue Shield Association Otezla (apremilast) Page 1 of 7 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Otezla (apremilast) Prime Therapeutics will review Prior Authorization requests Prior

More information

Medication Guide Enbrel (en-brel) (etanercept)

Medication Guide Enbrel (en-brel) (etanercept) Medication Guide Enbrel (en-brel) (etanercept) Read the Medication Guide that comes with Enbrel before you start using it and each time you get a refill. There may be new information. This Medication Guide

More information

Announcing HUMIRA. Psoriasis Starter Package

Announcing HUMIRA. Psoriasis Starter Package Announcing HUMIRA (adalimumab) Psoriasis Starter Package HUMIRA is indicated for the treatment of adult patients with moderate to severe chronic plaque psoriasis who are candidates for systemic therapy

More information

Ontario Public Drug Programs

Ontario Public Drug Programs Ontario Public Drug Programs Notice from the Executive Officer: Temporary Facilitated Access Mechanism (Rheumatology) for Ontario Drug Benefit Recipients aged 24 years and under December 14, 2017 Effective

More information

Clinical Policy: Biologic DMARDs Reference Number: CP.CPA.194 Effective Date: Last Review Date: Line of Business: Commercial

Clinical Policy: Biologic DMARDs Reference Number: CP.CPA.194 Effective Date: Last Review Date: Line of Business: Commercial Clinical Policy: Reference Number: CP.CPA.194 Effective Date: 01.01.18 Last Review Date: 12.17 Line of Business: Commercial Revision Log See Important Reminder at the end of this policy for important regulatory

More information

Decision relating to the funding of TNF inhibitors (Humira and Enbrel) and gabapentin (Neurontin)

Decision relating to the funding of TNF inhibitors (Humira and Enbrel) and gabapentin (Neurontin) 9 September 2015 Decision relating to the funding of TNF inhibitors (Humira and Enbrel) and gabapentin (Neurontin) The PHARMAC Board has approved the proposal relating to the funding of the TNF-inhibitor

More information

Humira (adalimumab) DRUG.00002

Humira (adalimumab) DRUG.00002 Humira (adalimumab) DRUG.00002 Override(s) Prior Authorization Quantity Limit Approval Duration 1 year Medications Humira 10 mg/0.2 ml syringe Humira pediatric Crohn s Disease starter pack 40 mg/0.8 ml

More information

Regulatory Status FDA approved indication: Kineret is an interleukin-1 receptor antagonist indicated for: (1)

Regulatory Status FDA approved indication: Kineret is an interleukin-1 receptor antagonist indicated for: (1) Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.50 Subject: Kineret Page: 1 of 5 Last Review Date: March 17, 2017 Kineret Description Kineret (anakinra)

More information

HARVARD PILGRIM HEALTH CARE RECOMMENDED MEDICATION REQUEST GUIDELINES HUMIRA PEDIATRIC

HARVARD PILGRIM HEALTH CARE RECOMMENDED MEDICATION REQUEST GUIDELINES HUMIRA PEDIATRIC Generic Brand HICL GCN Exception/Other ADALIMUMAB HUMIRA 24800 HUMIRA PEDIATRIC GUIDELINES FOR USE INITIAL CRITERIA (NOTE: FOR RENEWAL CRITERIA SEE BELOW) 1. Is the patient currently taking Humira? If

More information

Updates to the Alberta Drug Benefit List. Effective January 1, 2018

Updates to the Alberta Drug Benefit List. Effective January 1, 2018 Updates to the Alberta Drug Benefit List Effective January 1, 2018 Inquiries should be directed to: Pharmacy Services Alberta Blue Cross 10009 108 Street NW Edmonton AB T5J 3C5 Telephone Number: (780)

More information

INSTRUCTIONS FOR USE HUMIRA 40 MG/0.8 ML, 20 MG/0.4 ML AND 10 MG/0.2 ML SINGLE-USE PREFILLED SYRINGE

INSTRUCTIONS FOR USE HUMIRA 40 MG/0.8 ML, 20 MG/0.4 ML AND 10 MG/0.2 ML SINGLE-USE PREFILLED SYRINGE INSTRUCTIONS FOR USE HUMIRA (Hu-MARE-ah) (adalimumab) 40 MG/0.8 ML, 20 MG/0.4 ML AND 10 MG/0.2 ML SINGLE-USE PREFILLED SYRINGE Do not try to inject HUMIRA yourself until you have been shown the right way

More information

Tamala, treating her RA with ACTEMRA SC injections

Tamala, treating her RA with ACTEMRA SC injections escribing A PATIENT S GUIDE TO THE ACTEMRA PREFILLED SYRINGE Tamala, treating her RA with ACTEMRA SC injections INDICATION IMPORTANT SAFETY INFORMATION ACTEMRA is a prescription medicine called an interleukin-6

More information

Psoriatic Arthritis- Second Line Treatments

Psoriatic Arthritis- Second Line Treatments Psoriatic Arthritis- Second Line Treatments Second line treatments for Psoriatic Arthritis (PsA) are usually prescribed by a Rheumatologist, Dermatologist, or in a combined clinic where both the Dermatologist

More information

The Enbrel SureClick autoinjector is a single-dose prefilled autoinjector. It contains one 50 mg dose of Enbrel.

The Enbrel SureClick autoinjector is a single-dose prefilled autoinjector. It contains one 50 mg dose of Enbrel. Instructions for Use Welcome! The Enbrel SureClick autoinjector is a single-dose prefilled autoinjector. It contains one 50 mg dose of Enbrel. Your healthcare provider has prescribed Enbrel SureClick autoinjector

More information

Do you inject hormones? Yes, let s talk!

Do you inject hormones? Yes, let s talk! Do you inject hormones? Yes, let s talk! Safer Hormone Injection Guide What Are the Risks? If you are injecting your own hormones, it is important to know what s safe and what s not. Here s what you need

More information

MYALEPT (MAI-uh-lept) (metreleptin) for injection for subcutaneous use

MYALEPT (MAI-uh-lept) (metreleptin) for injection for subcutaneous use .3 mg per vial _ A healthcare provider should show you how to inject MYALEPT before you use it for the first time. A healthcare provider should also watch you inject your MYALEPT dose the first time you

More information

Introduction. Rheumatoid Arthritis. Rheumatoid Arthritis. Arthritis vs Rheumatoid Arthritis

Introduction. Rheumatoid Arthritis. Rheumatoid Arthritis. Arthritis vs Rheumatoid Arthritis Rheumatoid Arthritis Stuart Weisman, MD Boulder Medical Center, P.C. 303-622-3724 Introduction What is rheumatoid arthritis? How is it different than arthritis? What are the symptoms? How is it diagnosed?

More information

WARNING: RISK OF SERIOUS INFECTIONS

WARNING: RISK OF SERIOUS INFECTIONS RA PROGRESSION INTERRUPTED 1 DOSAGE AND ADMINISTRATION GUIDE No structural damage progression was observed at week 52 in 55.6% and in 47.8% of patients receiving KEVZARA 200 mg + MTX or 150 mg + MTX, compared

More information

Policy #: 061 Latest Review Date: October 2013

Policy #: 061 Latest Review Date: October 2013 Name of Policy: TNF Antagonists and Other Biologics Policy #: 061 Latest Review Date: October 2013 Category: Pharmacy Policy Grade: A Background/Definitions: As a general rule, benefits are payable under

More information

UnitedHealthcare Pharmacy Clinical Pharmacy Programs

UnitedHealthcare Pharmacy Clinical Pharmacy Programs UnitedHealthcare Pharmacy Clinical Pharmacy Programs Program Number 2017 P 1041-8 Program Prior Authorization/Notification Medication Humira (adalimumab) P&T Approval Date 1/2007, 6/2008, 4/2009, 6/2009,

More information

Therapeutic Agents in Rheumatic and Inflammatory Diseases Drug Class Prior Authorization Protocol

Therapeutic Agents in Rheumatic and Inflammatory Diseases Drug Class Prior Authorization Protocol Therapeutic Agents in Rheumatic and Inflammatory Diseases Drug Class Prior Authorization Protocol Line of Business: Medi-Cal Effective Date: August 16, 2017 Revision Date: August 16, 2017 This policy has

More information

Instructions for Use HEMLIBRA (hem-lee-bruh) (emicizumab-kxwh) injection, for subcutaneous use

Instructions for Use HEMLIBRA (hem-lee-bruh) (emicizumab-kxwh) injection, for subcutaneous use Instructions for Use HEMLIBRA (hem-lee-bruh) (emicizumab-kxwh) injection, for subcutaneous use Be sure that you read, understand, and follow the Instructions for Use before injecting HEMLIBRA. Your healthcare

More information

Biologic Immunomodulators Prior Authorization and Quantity Limit Program Summary (Specialty Drug Management)

Biologic Immunomodulators Prior Authorization and Quantity Limit Program Summary (Specialty Drug Management) RA PSA AS PS UC CD PJIA SJIA HS UVEITIS CAPS/NOMID GIANT CELL ARTERITIS Horizon BCBSNJ Medical Necessity Guideline Biologic Immunomodulators Prior Authorization and Quantity Limit Program Summary (Specialty

More information

TNF Inhibitors: Lessons From Immunogenicity

TNF Inhibitors: Lessons From Immunogenicity TNF Inhibitors: Lessons From Immunogenicity Edward Keystone, MD, FRCP(C) Professor of Medicine University of Toronto Toronto, Canada Edward Keystone, MD FRCP(C) Disclosures Sources of Funding for Research:

More information

Pharmacy Medical Necessity Guidelines:

Pharmacy Medical Necessity Guidelines: Pharmacy Medical Necessity Guidelines: Effective: January 1, 2018 Prior Authorization Required Type of Review Care Management Not Covered Type of Review Clinical Review Pharmacy (RX) or Medical (MED) Benefit

More information

INFLIXIMAB Remicade (infliximab), Inflectra (infliximab-dyyb), Renflexis (infliximab-abda)

INFLIXIMAB Remicade (infliximab), Inflectra (infliximab-dyyb), Renflexis (infliximab-abda) RATIONALE FOR INCLUSION IN PA PROGRAM Background Remicade, Renflexis and Inflectra are tumor necrosis factor (TNFα) blockers. Tumor necrosis factor is an endogenous protein that regulates a number of physiologic

More information

ACTEMRA (tocilizumab)

ACTEMRA (tocilizumab) RATIONALE FOR INCLUSION IN PA PROGRAM Background Actemra is an agent in the class of drugs known as biologic disease modifiers. It is used to treat adult onset rheumatoid (RA) arthritis, polyarticular

More information

Guide. Healthcare Professional Administration and Monitoring

Guide. Healthcare Professional Administration and Monitoring Healthcare Professional Administration and Monitoring Guide CIMZIA, in combination with methotrexate, is indicated for the treatment of moderate to severe, active rheumatoid arthritis (RA) in adult patients

More information

Using ENBREL to Treat Rheumatoid and Psoriatic Arthritis

Using ENBREL to Treat Rheumatoid and Psoriatic Arthritis Using ENBREL to Treat Rheumatoid and Psoriatic Arthritis Writing White Papers class Bellevue Community College TABLE OF CONTENTS TABLE OF CONTENTS...2 OVERVIEW...3 RHEUMATOID ARTHRITIS... 3 JUVENILE RHEUMATOID

More information

Pharmacy Medical Necessity Guidelines: Simponi and Simponi Aria (golimumab)

Pharmacy Medical Necessity Guidelines: Simponi and Simponi Aria (golimumab) Pharmacy Medical Necessity Guidelines: Simponi and Simponi Aria (golimumab) Effective: November 20, 2017 Prior Authorization Required Type of Review Care Management Not Covered Type of Review Clinical

More information

REMICADE Infliximab Consumer Medicine Information

REMICADE Infliximab Consumer Medicine Information REMICADE Infliximab Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about It does not contain all the available information. It does not take the place

More information

Drug Class Update: Biologics for Autoimmune Conditions

Drug Class Update: Biologics for Autoimmune Conditions Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119

More information

Patient #1. Rheumatoid Arthritis. Rheumatoid Arthritis. 45 y/o female Morning stiffness in her joints >1 hour

Patient #1. Rheumatoid Arthritis. Rheumatoid Arthritis. 45 y/o female Morning stiffness in her joints >1 hour Patient #1 Rheumatoid Arthritis Essentials For The Family Medicine Physician 45 y/o female Morning stiffness in her joints >1 hour Hands, Wrists, Knees, Ankles, Feet Polyarticular, symmetrical swelling

More information

Inflectra (infliximab-dyyb), Remicade (infliximab), Renflexis (infliximab-abda) DRUG CG-DRUG-64

Inflectra (infliximab-dyyb), Remicade (infliximab), Renflexis (infliximab-abda) DRUG CG-DRUG-64 Inflectra (infliximab-dyyb), Remicade (infliximab), Renflexis (infliximab-abda) DRUG.00002 CG-DRUG-64 Override(s) Prior Authorization *Washington Medicaid See State Specific Mandates Medications Inflectra

More information

ACTEMRA (tocilizumab)

ACTEMRA (tocilizumab) ACTEMRA (tocilizumab) Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs

More information

Cigna Drug and Biologic Coverage Policy

Cigna Drug and Biologic Coverage Policy Cigna Drug and Biologic Coverage Policy Subject Apremilast Table of Contents Coverage Policy... 1 General Background... 2 Coding/Billing Information... 4 References... 4 Effective Date... 1/1/2018 Next

More information

Clinical Policy: Ustekinumab (Stelara) Reference Number: CP.PHAR.264

Clinical Policy: Ustekinumab (Stelara) Reference Number: CP.PHAR.264 Clinical Policy: (Stelara) Reference Number: CP.PHAR.264 Effective Date: 08/16 Last Review Date: 05/16 Coding Implications Revision Log See Important Reminder at the end of this policy for important regulatory

More information

Pharmacy Medical Necessity Guidelines: Stelara (ustekinumab)

Pharmacy Medical Necessity Guidelines: Stelara (ustekinumab) Pharmacy Medical Necessity Guidelines: Effective: January 1, 2018 Type of Review Care Prior Authorization Required Management Not Covered Type of Review Clinical Review SQ: RX/ Pharmacy (RX) or Medical

More information

Actemra Pre-filled syringe pronounced (Act-tem-ra)

Actemra Pre-filled syringe pronounced (Act-tem-ra) Actemra Pre-filled syringe pronounced (Act-tem-ra) contains the active ingredient tocilizumab (rch) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about

More information

Before you use the TALTZ autoinjector, read and carefully follow all the step-by-step instructions.

Before you use the TALTZ autoinjector, read and carefully follow all the step-by-step instructions. 1 INSTRUCTIONS FOR USE TALTZ (tȯl(t)s) (ixekizumab) injection, for subcutaneous use Autoinjector Before you use the TALTZ autoinjector, read and carefully follow all the step-by-step instructions. Important

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: (Rituxan), and Hyaluronidase (Rituxan Hycela) Reference Number: CP.CPA.147 Effective Date: 11.11.16 Last Review Date: 11.17 Line of Business: Commercial Revision Log See Important Reminder

More information

Renflexis (infliximab-abda)

Renflexis (infliximab-abda) Renflexis (infliximab-abda) Last Review Date: 04/25/2017 Date of Origin: 04/25/2017 Dates Reviewed: 04/2017 Document Number: MODA-0300 I. Length of Authorization Coverage is provided for 6 months and may

More information

Psoriatic arthritis FACTSHEET

Psoriatic arthritis FACTSHEET 1 What is psoriatic arthritis? Psoriatic arthritis (PsA) is a disease where joints around the body become inflamed and sore. It can make moving about difficult and painful. People who have PsA also have

More information

Breakfast Session Dr Sarah Jordan Rheumatology Clinical Lecturer Dunedin

Breakfast Session Dr Sarah Jordan Rheumatology Clinical Lecturer Dunedin Breakfast Session Dr Sarah Jordan Rheumatology Clinical Lecturer Dunedin Ankylosing spondylitis, Psoriatic Arthritis... And the others The Spondyloarthropathies (SpA) Sarah Jordan Rheumatologist Spondyloarthropathies

More information

Subcutaneous Methotrexate for Rheumatoid Arthritis

Subcutaneous Methotrexate for Rheumatoid Arthritis DRUG NEWS Subcutaneous Methotrexate for Rheumatoid Arthritis Summary Subcutaneous administration of methotrexate is recommended in the treatment of rheumatoid arthritis by the Canadian Rheumatology Association

More information

Technology appraisal guidance Published: 16 December 2015 nice.org.uk/guidance/ta373

Technology appraisal guidance Published: 16 December 2015 nice.org.uk/guidance/ta373 Abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis Technology appraisal guidance Published: 16 December 2015 nice.org.uk/guidance/ta373 NICE 2017. All rights reserved.

More information

Medications Guide June 2017

Medications Guide June 2017 s Guide June 2017 Arthritis Consumer Experts (ACE) produces its annual JointHealth Medications Guide to enable members/patients-at-large to have a meaningful conversation with their rheumatologist and

More information

Drug Class Update with New Drug Evaluation: Biologics for Autoimmune Conditions

Drug Class Update with New Drug Evaluation: Biologics for Autoimmune Conditions Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119

More information

Technology appraisal guidance Published: 11 October 2017 nice.org.uk/guidance/ta480

Technology appraisal guidance Published: 11 October 2017 nice.org.uk/guidance/ta480 Tofacitinib for moderate to severeere rheumatoid arthritis Technology appraisal guidance Published: 11 October 2017 nice.org.uk/guidance/ta480 NICE 2018. All rights reserved. Subject to Notice of rights

More information

Ulcerative Colitis Therapy. Faculty Disclosure. Acknowledgements 28/11/2013. Amy Morse November 30/13

Ulcerative Colitis Therapy. Faculty Disclosure. Acknowledgements 28/11/2013. Amy Morse November 30/13 Ulcerative Colitis Therapy Amy Morse November 30/13 GI for GP s Jasper AB Faculty Disclosure Faculty: Amy Morse Relationships with commercial interests: Grants/Research Support: Therapeutic Fellowship

More information

A Guide to Treatment with Serostim

A Guide to Treatment with Serostim A Guide to Treatment with Serostim If you have been recently diagnosed with HIV-associated wasting and prescribed Serostim [somatropin (rdna origin) for injection], this guide has been designed to help

More information

HUMIRA (adalimumab) injection, for subcutaneous use Initial U.S. Approval: 2002

HUMIRA (adalimumab) injection, for subcutaneous use Initial U.S. Approval: 2002 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use HUMIRA safely and effectively. See full prescribing information for HUMIRA. HUMIRA (adalimumab) injection,

More information

New patients approved for the Novo Nordisk PAP may only be eligible for insulin vials. For a full list of available products, please visit:

New patients approved for the Novo Nordisk PAP may only be eligible for insulin vials. For a full list of available products, please visit: The Novo Nordisk Diabetes Patient Assistance Program (PAP) provides medication to qualifying applicants at no charge. If the applicant qualifies under the Novo Nordisk Diabetes PAP guidelines, a 120-day

More information

PATIENT INFORMATION LEAFLET MEDICINE TO TREAT: DIABETES. Insulin

PATIENT INFORMATION LEAFLET MEDICINE TO TREAT: DIABETES. Insulin PATIENT INFORMATION LEAFLET MEDICINE TO TREAT: DIABETES Insulin This medicine has been proven to be safe and effective, but it can cause serious injury if a mistake happens while taking it. This means

More information

Outline. Biologic Drugs in Inflammatory Bowel Disease Dr. Jason Etzel MD The Vancouver Clinic. Biologic Drugs. Biologic Drugs. Biologic Drugs Anti-TNF

Outline. Biologic Drugs in Inflammatory Bowel Disease Dr. Jason Etzel MD The Vancouver Clinic. Biologic Drugs. Biologic Drugs. Biologic Drugs Anti-TNF Outline Biologic Drugs in Inflammatory Bowel Disease Dr. Jason Etzel MD The Vancouver Clinic Types of biologic drugs How do they work? How effective are they? Safety/Toxicity concerns with biologics Biologic

More information

Infliximab Remicade (infliximab) Inflectra (infliximab-dyyb) Renflexis (infliximab-abda)

Infliximab Remicade (infliximab) Inflectra (infliximab-dyyb) Renflexis (infliximab-abda) Infliximab Remicade (infliximab) Inflectra (infliximab-dyyb) Renflexis (infliximab-abda) Line(s) of Business: HMO; PPO; QUEST Integration Akamai Advantage Original Effective Date: 11/18/2003 Current Effective

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Measurement of Serum Antibodies to Infliximab, Adalimumab and File Name: Origination: Last CAP Review: Next CAP Review: Last Review: measurement_of_serum_antibodies_to_infliximab_and_adalimumab

More information

Traveling with Inflammatory Bowel Disease. Suresh Pola MD Inflammatory Bowel Disease Center UC San Diego Health System

Traveling with Inflammatory Bowel Disease. Suresh Pola MD Inflammatory Bowel Disease Center UC San Diego Health System Traveling with Inflammatory Bowel Disease Suresh Pola MD Inflammatory Bowel Disease Center UC San Diego Health System Overview What You Need to Do Now Pre-Travel Preparation While You Are Away When You

More information

Key words: rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, treatment access

Key words: rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, treatment access 6, 21...,.,..,..,. - (RA) -,. (AS) (PsA). (Disease-modifying antirheumatic drugs, DMARDs). DMARDs 21. - RA, AS PsA. 21. RA, DMARDs. Leflunomide (Arava)., RA Methotrexate Leflunomid. DMARDs - 5 29. - RA

More information

THE CIMZIA PATIENT GUIDE. what you need to know to get started. For internal use only. CZP-PRM :GPSRC Patient Starter Kit

THE CIMZIA PATIENT GUIDE. what you need to know to get started. For internal use only. CZP-PRM :GPSRC Patient Starter Kit THE CIMZIA PATIENT GUIDE what you need to know to get started For internal use only. CZP-PRM-005483:GPSRC Patient Starter Kit What this booklet is for You re reading this booklet because you have been

More information

User Manual Important: First read the Medication Guide that comes inside your FORTEO carton.

User Manual Important: First read the Medication Guide that comes inside your FORTEO carton. FORTEO (for-tay-o) teriparatide (rdna origin) injection 1 User Manual Important: First read the Medication Guide that comes inside your FORTEO carton. Before you use your new FORTEO delivery device, please

More information

Y. Yazici 1, B.J. McMorris 2, T. Darkow 2, L.C. Rosenblatt 3

Y. Yazici 1, B.J. McMorris 2, T. Darkow 2, L.C. Rosenblatt 3 Patient and physician perception of the infusion process of the biologic agents abatacept, infliximab, and rituximab for the treatment of rheumatoid arthritis Y. Yazici 1, B.J. McMorris 2, T. Darkow 2,

More information

IMPORTANT: PLEASE READ

IMPORTANT: PLEASE READ IMPORTANT: PLEASE READ PART III: CONSUMER INFORMATION PLEGRIDY TM (pronounced PLEGG-rih-dee) PLEGRIDY TM PS (peginterferon beta- 1a) pre-filled syringe PLEGRIDY TM PEN (peginterferon beta- 1a) pre-filled

More information

EVER Pharma D-mine Pen Pen injector for Apomorphine 10 mg/ml

EVER Pharma D-mine Pen Pen injector for Apomorphine 10 mg/ml EVER Pharma D-mine Pen Pen injector for Apomorphine 10 mg/ml Instructions for Use with Dacepton 3 ml Cartridges Apomorphine hydrochloride hemihydrate solution for injection Subcutaneous Use TABLE OF CONTENTS

More information

PROFESSIONAL MEMBERSHIPS

PROFESSIONAL MEMBERSHIPS June 2012 January 2014 October 2009 May 2012 Staff Rheumatologist, Diagnostic Clinic, Clearwater, FL Staff Rheumatologist, Arthritis Associates, Palm Harbor, FL 2008 2012 Co-Investigator, Arthritis Research

More information

SHARED CARE AGREEMENT: METHOTREXATE S/C

SHARED CARE AGREEMENT: METHOTREXATE S/C NB: This document should be read in conjunction with the current Summary of Product Characteristics (SPC) and BSR Guideline for disease-modifying anti-rheumatic drug (DMARD) therapy (available at www.rheumatology.org.uk/resources/guidelines/bsr_guidelines.aspx

More information

LEUCOVORIN-TEVA 10 mg/ml CONCENTRATE FOR SOLUTION FOR INFUSION folinic acid as the calcium salt PACKAGE LEAFLET: INFORMATION FOR THE USER

LEUCOVORIN-TEVA 10 mg/ml CONCENTRATE FOR SOLUTION FOR INFUSION folinic acid as the calcium salt PACKAGE LEAFLET: INFORMATION FOR THE USER LEUCOVORIN-TEVA 10 mg/ml CONCENTRATE FOR SOLUTION FOR INFUSION folinic acid as the calcium salt PACKAGE LEAFLET: INFORMATION FOR THE USER Read all of this leaflet carefully before you start using this

More information

2017 Medicare STARs Provider Quality Indicators Guide

2017 Medicare STARs Provider Quality Indicators Guide 2017 Medicare STARs Provider Quality Indicators Guide Medicare STARs Rating Centers for Medicare & Medicaid Services (CMS) created a Five-Star Quality Rating System to help measure the quality in care

More information

HOW TO USE YOUR LANTUS SOLOSTAR PEN

HOW TO USE YOUR LANTUS SOLOSTAR PEN HOW TO USE YOUR LANTUS SOLOSTAR PEN A STEP BY STEP GUIDE TO USING YOUR LANTUS SOLOSTAR PEN This quick reference guide is a short version of the instruction leaflet. It is designed to help make it easier

More information

Revision Log. See Important Reminder at the end of this policy for important regulatory and legal information.

Revision Log. See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: (DDAVP, Noctiva, Stimate) Reference Number: CP.CPA.## [Pre-P&T approval] Effective Date: 05/02/17 Last Review Date: 05/17 Line of Business: Medicaid - HNMC Revision Log See Important Reminder

More information

Saxenda (liraglutide injection 3 mg) Patient Information

Saxenda (liraglutide injection 3 mg) Patient Information Who Is Saxenda For? Saxenda is a medication for chronic weight management. It is for people with overweight and weight-related complications or obesity. It is meant to be used together with a lifestyle

More information

RETIRED. Maximum Drug Dose Policy

RETIRED. Maximum Drug Dose Policy RETIRED DRUG POLICY Policy Number 2017D0034A Maximum Drug Dose Policy Annual Approval Date 3/1/2017 Approved By UnitedHealthcare National Pharmacy & Therapeutics Committee United Healthcare Community Plan

More information

AMJEVITA (adalimumab-atto) injection for subcutaneous use. Initial U.S. Approval: 2016

AMJEVITA (adalimumab-atto) injection for subcutaneous use. Initial U.S. Approval: 2016 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use AMJEVITA TM safely and effectively. See full prescribing information for AMJEVITA. AMJEVITA (adalimumab-atto)

More information

Pharmacy Medical Necessity Guidelines: Stelara (ustekinumab)

Pharmacy Medical Necessity Guidelines: Stelara (ustekinumab) Pharmacy Medical Necessity Guidelines: Effective: November 14, 2017 Prior Authorization Required Type of Review Care Management Not Covered Type of Review Clinical Review SQ: RXUM/ RX / Pharmacy (RX) or

More information

777 Old Saw Mill River Road Tarrytown, NY Copyright 2008, Regeneron Pharmaceuticals, Inc. ARC-0007-PB-10.09

777 Old Saw Mill River Road Tarrytown, NY Copyright 2008, Regeneron Pharmaceuticals, Inc. ARC-0007-PB-10.09 REG43214_Patient_Covers_FINAL:Layout 1 10/13/08 1:18 PM Page 1 References 1. ARCALYST (rilonacept) for Subcutaneous Injection full Prescribing Information. 2. Aksentijevich I, Putnam CD, Remmers EF, Mueller

More information

GLEEVEC (imatinib mesylate) PATIENT RESOURCES

GLEEVEC (imatinib mesylate) PATIENT RESOURCES Talking with your doctor about Ph+ CML and its treatment When you have Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML), it s important to take an active role in your care. You will

More information

Giving Medicine by Subcutaneous Injection

Giving Medicine by Subcutaneous Injection Giving Medicine by Subcutaneous Injection A subcutaneous injection, also called a sub Q or SQ shot, is one that is given into the layers of skin and fat on top of the muscle. Follow these steps for giving

More information

Relief, true to form

Relief, true to form For adults with Chronic Idiopathic Constipation (CIC) or Irritable Bowel Syndrome with Constipation (IBS-C) Relief, true to form When It Comes to Constipation Relief, Form Matters Trulance can help you

More information

POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY

POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY Original Issue Date (Created): October 29, 2002 Most Recent Review Date (Revised): March 25, 2014 Effective Date: August 6, 2014 POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT

More information

ACTEMRA SC formulation is not intended for intravenous administration.

ACTEMRA SC formulation is not intended for intravenous administration. HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ACTEMRA safely and effectively. See full prescribing information for ACTEMRA. ACTEMRA (tocilizumab)

More information

Rituxan. Rituxan (rituximab) Description

Rituxan. Rituxan (rituximab) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.04.10 Subject: Rituxan Page: 1 of 9 Last Review Date: December 3, 2015 Rituxan Description Rituxan (rituximab)

More information

Supplementary Materials for

Supplementary Materials for immunology.sciencemag.org/cgi/content/full/1/2/eaah3539/dc1 Supplementary Materials for IL-1 is an innate immune sensor of microbial proteolysis Christopher N. LaRock,* Jordan Todd, Doris L. LaRock, Joshua

More information

PEN USER MANUAL Byetta 5 micrograms solution for injection in pre-filled pen (exenatide)

PEN USER MANUAL Byetta 5 micrograms solution for injection in pre-filled pen (exenatide) PEN USER MANUAL Byetta 5 micrograms solution for injection in pre-filled pen (exenatide) Section 1. WHAT YOU NEED TO KNOW ABOUT YOUR BYETTA PEN Read this section completely before you begin. Then, move

More information